These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 8236126

  • 1. Effect of three fibrate derivatives and of two HMG-CoA reductase inhibitors on plasma fibrinogen level in patients with primary hypercholesterolemia.
    Branchi A, Rovellini A, Sommariva D, Gugliandolo AG, Fasoli A.
    Thromb Haemost; 1993 Aug 02; 70(2):241-3. PubMed ID: 8236126
    [Abstract] [Full Text] [Related]

  • 2. Effects of bezafibrate and of 2 HMG-CoA reductase inhibitors on lipoprotein (a) level in hypercholesterolemic patients.
    Branchi A, Rovellini A, Fiorenza AM, Sommariva D.
    Int J Clin Pharmacol Ther; 1995 Jun 02; 33(6):345-50. PubMed ID: 7582386
    [Abstract] [Full Text] [Related]

  • 3. Treatment of heterozygous familial hypercholesterolemia with lipid-lowering drugs.
    Illingworth DR, Bacon S.
    Arteriosclerosis; 1989 Jun 02; 9(1 Suppl):I121-34. PubMed ID: 2492189
    [Abstract] [Full Text] [Related]

  • 4. Effect of hydroxymethylglutaryl-CoA reductase inhibitors on the functional properties of erythrocyte membranes.
    Rabini RA, Polenta M, Staffolani R, Tocchini M, Signore R, Testa I, Mazzanti L.
    Exp Mol Pathol; 1993 Aug 02; 59(1):51-7. PubMed ID: 8262165
    [Abstract] [Full Text] [Related]

  • 5. Efficacy, safety and tolerability of lovastatin and bezafibrate retard in patients with hypercholesterolemia.
    Schumacher M, Eber B, Silberbauer K, Breier C, Stühlinger W, Schmidt P, Gaul G, Klein W.
    Acta Med Austriaca; 1992 Aug 02; 19(5):140-4. PubMed ID: 1298143
    [Abstract] [Full Text] [Related]

  • 6. Comparison of combined statin-fibrate treatment to monotherapy in patients with mixed hyperlipidemia.
    Kłosiewicz-Latoszek L, Szostak WB, Grzybowska B, Białobrzeska-Paluszkiewicz J, Wiśniewska B, Stolarska I.
    Kardiol Pol; 2004 Jun 02; 60(6):567-77. PubMed ID: 15334157
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the efficacy of simvastatin and standard fibrate therapy in the treatment of primary hypercholesterolemia and combined hyperlipidemia.
    Bruckert E, De Gennes JL, Malbecq W, Baigts F.
    Clin Cardiol; 1995 Nov 02; 18(11):621-9. PubMed ID: 8590530
    [Abstract] [Full Text] [Related]

  • 8. Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study.
    Akçiçek F, Ok E, Duman S, Kürsad S, Unsal A, Alev M, Atabay G, Basçi A.
    Adv Perit Dial; 1996 Nov 02; 12():261-5. PubMed ID: 8865916
    [Abstract] [Full Text] [Related]

  • 9. The effects of simvastatin and pravastatin on objective and subjective measures of nocturnal sleep: a comparison of two structurally different HMG CoA reductase inhibitors in patients with primary moderate hypercholesterolaemia.
    Eckernäs SA, Roos BE, Kvidal P, Eriksson LO, Block GA, Neafus RP, Haigh JR.
    Br J Clin Pharmacol; 1993 Mar 02; 35(3):284-9. PubMed ID: 8471404
    [Abstract] [Full Text] [Related]

  • 10. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia.
    Pappu AS, Bacon SP, Illingworth DR.
    J Lab Clin Med; 2003 Apr 02; 141(4):250-6. PubMed ID: 12677170
    [Abstract] [Full Text] [Related]

  • 11. Effects of fluvastatin and bezafibrate combination on plasma fibrinogen, t-plasminogen activator inhibitor and C reactive protein levels in coronary artery disease patients with mixed hyperlipidaemia (FACT study). Fluvastatin Alone and in Combination Treatment.
    Cortellaro M, Cofrancesco E, Boschetti C, Cortellaro F, Mancini M, Mariani M, Paoletti R.
    Thromb Haemost; 2000 Apr 02; 83(4):549-53. PubMed ID: 10780315
    [Abstract] [Full Text] [Related]

  • 12. [The effect of micronized fenofibrate on lipid parameters and fibrinogen in heterozygous familial hypercholesterolemia and familial combined hyperlipidemia].
    Ceska R, Sobra J, Kvasnicka J, Procházková R, Kvasilová M, Haas T.
    Cas Lek Cesk; 1996 Jul 26; 135(13):413-6. PubMed ID: 8925538
    [Abstract] [Full Text] [Related]

  • 13. Effects of gemfibrozil and ciprofibrate on plasma levels of tissue-type plasminogen activator, plasminogen activator inhibitor-1 and fibrinogen in hyperlipidaemic patients.
    Kockx M, de Maat MP, Knipscheer HC, Kastelein JJ, Kluft C, Princen HM, Kooistra T.
    Thromb Haemost; 1997 Oct 26; 78(4):1167-72. PubMed ID: 9364979
    [Abstract] [Full Text] [Related]

  • 14. Dietary management of patients with familial hypercholesterolaemia treated with simvastatin.
    Chisholm A, Mann J, Sutherland W, Williams S, Ball M.
    Q J Med; 1992 Oct 26; 85(307-308):825-31. PubMed ID: 1484945
    [Abstract] [Full Text] [Related]

  • 15. Effects of two different fibric acid derivatives on lipoproteins, cholesteryl ester transfer, fibrinogen, plasminogen activator inhibitor and paraoxonase activity in type IIb hyperlipoproteinaemia.
    Durrington PN, Mackness MI, Bhatnagar D, Julier K, Prais H, Arrol S, Morgan J, Wood GN.
    Atherosclerosis; 1998 May 26; 138(1):217-25. PubMed ID: 9678787
    [Abstract] [Full Text] [Related]

  • 16. Similar effects of atorvastatin, simvastatin and pravastatin on thrombogenic and inflammatory parameters in patients with hypercholesterolemia.
    Joukhadar C, Klein N, Prinz M, Schrolnberger C, Vukovich T, Wolzt M, Schmetterer L, Dorner GT.
    Thromb Haemost; 2001 Jan 26; 85(1):47-51. PubMed ID: 11204586
    [Abstract] [Full Text] [Related]

  • 17. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs.
    Davis HR, Pula KK, Alton KB, Burrier RE, Watkins RW.
    Metabolism; 2001 Oct 26; 50(10):1234-41. PubMed ID: 11586500
    [Abstract] [Full Text] [Related]

  • 18. [Efficacy of blood lipid normalization and tolerance in dyslipidemic patients treated for 18 months with fibric acid derivatives].
    Arsenio L, Rossi A.
    Clin Ter; 1989 Dec 31; 131(6):403-12. PubMed ID: 2534369
    [Abstract] [Full Text] [Related]

  • 19. [The HMG-CoA reductase inhibitors simvastatin and pravastatin. No indication for side effects in use on humans].
    Schmidt J, Schmitt C, Hockwin O.
    Fortschr Ophthalmol; 1991 Dec 31; 88(6):843-5. PubMed ID: 1794817
    [Abstract] [Full Text] [Related]

  • 20. [Antilipemic agents and atherothrombosis. Effects of antilipemic agents on blood platelet function, coagulation and fibrinolysis].
    Sinzinger H.
    Dtsch Med Wochenschr; 1998 Sep 18; 123(38):1116-22. PubMed ID: 9787294
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.